Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis
Archives of Medical Research · 2026
DOI: 10.1016/j.arcmed.2025.103283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Medical Research, 2026. Verfasst von Meican Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, C…. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Arthritis, Rheumatoid, Muscle Proteins, Synovial Membrane. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Wuxi Municipal Bureau on Science and Technology, Nanjing Medical University, Wuxi Science and Technology Association.
Abstract (Originalsprache)
OBJECTIVES: In hypoxic conditions, the acidic environment characteristic of rheumatoid arthritis (RA) induces metabolic changes in fibroblast-like synoviocytes (FLS), markedly promoting the synovial proliferation. Monocarboxylate transporter 4 (MCT4) plays a crucial role in cellular pH regulation and synovial fibroblast activation by regulating lactate export. This study investigates the impact of MCT4 inhibition on RA and elucidates its underlying mechanisms. METHOD: RA-FLS cells were treated with siMCT4 and VB124 (a selective MCT4 inhibitor), significantly affecting glucose and glutamine uptake and altering lactate efflux. Metabolite analysis using liquid chromatography-mass spectrometry (LC-MS) revealed the mechanisms of carbon metabolism reprogramming. ChIP-qPCR analysis demonstrated changes in hypoxia-inducible factor-1α (HIF1-α) binding to the MCT4 promoter. The therapeutic effects of siMCT4 and VB124 were validated in a collagen-induced arthritis (CIA) model, and their efficacy was assessed through arthritis scores and histological examination. RESULTS: In patients with RA, MCT4 levels are significantly elevated. Inhibition of MCT4 effectively reduces synovial hyperproliferation and impacts metabolic reprogramming. Specifically, blocking MCT4 in RA-FLS reduces glucose consumption and lactate production while remodeling the metabolic landscape by increasing fumarate, citrate, and malate levels, and decreasing glucose-6-phosphate and aspartate levels. This metabolic shift is accompanied by improvements in mitochondrial structure and function, reduced mitochondrial swelling, and decreased oxidative stress, underscoring the relationship between MCT4 inhibition and cellular energetics. Furthermore, our investigations reveal that HIF1-α directly regulates MCT4 activation, providing a molecular mechanism by which hypoxia promotes MCT4-mediated metabolic reprogramming. CONCLUSION: These findings highlight MCT4 as a central regulator of RA proliferation and a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
- The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China. Electronic address: Yfh222222@163.com.
Förderung
- Wuxi Municipal Bureau on Science and Technology
- Nanjing Medical University
- Wuxi Science and Technology Association
Zitieren
APA
Ma, M., Liu, T., Chen, H., Wang, Z., Zhou, J., Zhou, Y., & Yuan, F. (2026). Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis. Archives of Medical Research. https://doi.org/10.1016/j.arcmed.2025.103283
Vancouver
Ma M, Liu T, Chen H, Wang Z, Zhou J, Zhou Y, et al. Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis. Archives of Medical Research. 2026. doi:10.1016/j.arcmed.2025.103283
BibTeX
@article{Ma2026,
author = {Ma, Meican and Liu, Ting and Chen, Haifeng and Wang, Zhao and Zhou, Jie and Zhou, Yu and Yuan, Fenghong},
title = {Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis},
journal = {Archives of Medical Research},
year = {2026},
doi = {10.1016/j.arcmed.2025.103283}
}
EUVIMED